Core Viewpoint - A lawsuit has been filed against Firefly Aerospace Inc. alleging that the company made false statements regarding its business prospects and operational readiness, which may have led to financial losses for investors [2][3]. Group 1: Lawsuit Details - The lawsuit represents a class of individuals and entities that purchased Firefly common stock during its initial public offering on August 7, 2025, and those who acquired securities between August 7, 2025, and September 29, 2025 [2]. - The complaint claims that Firefly overstated demand and growth prospects for its Spacecraft Solutions offerings and the operational readiness of its Alpha rocket program, which could have a material negative impact on the company [3]. Group 2: Next Steps for Investors - Investors who suffered losses in Firefly Aerospace Inc. stock during the specified timeframe are encouraged to seek information about their rights to recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP is highlighted as a nationally-recognized securities litigation firm with a strong track record in securing recoveries for shareholders, having ranked in the Top 50 Report for seven consecutive years [5].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Wildermuth Fund To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired in The Wildermuth Fund between November 1, 2020 and June 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - Nov ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Baxter International Inc. due to allegations of false and misleading statements regarding the Novum LVP medical device, which has been linked to serious malfunctions and patient risks [2][5]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in Baxter between February 23, 2022, and July 30, 2025, to discuss their legal rights [1]. - A federal securities class action has been filed against Baxter, with a deadline of December 15, 2025, for investors to seek the role of lead plaintiff [2]. Group 2: Allegations Against Baxter - The complaint alleges that Baxter and its executives violated federal securities laws by failing to disclose systemic defects in the Novum LVP, which caused malfunctions that could lead to serious injury or death [5]. - Baxter was reportedly aware of multiple device malfunctions and injuries but did not take adequate remedial measures, leading to a heightened risk of product withdrawal from the market [5]. Group 3: Stock Impact - The extent of the alleged fraud was revealed on July 31, 2025, when Baxter announced a voluntary pause in shipments and installations of the Novum LVP, resulting in a 22.4% drop in stock price, closing at $21.76 [6].

Core Insights - Stride, Inc. is under investigation by Levi & Korsinsky for potential violations of federal securities laws following disappointing enrollment numbers and guidance despite beating earnings expectations [1][2]. Financial Performance - Stride reported its first quarter fiscal 2026 earnings on October 28, 2025, with earnings exceeding expectations; however, enrollment numbers and forward-looking guidance were significantly below expectations [2]. - The company has invested in upgrading its learning and technology platforms, but the implementations faced challenges, leading to higher withdrawal rates and lower conversion rates than anticipated [2]. Stock Market Reaction - Following the earnings report, Stride's stock price dropped by $68.51 per share, opening at $85.02 per share [3].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In CarMax To Contact Him Directly To Discuss Their OptionsIf you suffered losses in CarMax between June 20, 2025 and September 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - November 13, 2025) - Faruqi & Far ...

Core Viewpoint - A securities class action has been filed against Telix Pharmaceuticals Ltd. for alleged violations of the Securities Exchange Act of 1934, with a class period from February 21, 2025, to August 28, 2025, and investors have until January 9, 2026, to seek appointment as lead plaintiff [1]. Allegations - The lawsuit alleges that Telix and its executives overstated progress on the company's prostate cancer therapeutic candidates [6]. - The company is also accused of overstating the quality of its supply chain and partner operations [6]. Key Events - On February 20, 2025, Telix held an earnings call where executives claimed significant progress in their therapeutic pipeline, particularly in prostate cancer, which was said to be in Phase 3 [6]. - On July 22, 2025, Telix reported to the SEC that it received a subpoena regarding its prostate cancer therapeutic candidates, leading to a 16% drop in share price, the largest decline in 21 months [6]. - Following the subpoena news, Telix ADSs fell by $1.70 (10.4%) to close at $14.58 on July 23, 2025, and further dropped by $0.69 (4.7%) to close at $13.89 on July 24, 2025 [6]. - On August 28, 2025, Telix announced that the FDA issued a Complete Response Letter for its renal cancer drug candidate, resulting in a $1.95 (16.1%) drop in share price to close at $10.15 [6]. - The following day, Telix ADSs fell an additional $0.60 (5.9%) to close at $9.55 on August 29, 2025 [6].

Core Insights - Holzer & Holzer, LLC is investigating Trex Company, Inc. for potential compliance issues with federal securities laws following the announcement of lower-than-expected third quarter sales on November 4, 2025 [1] - Trex is working with its channel partners to reduce inventory levels as it adjusts production in response to the sales decline [1] - The announcement of disappointing financial results led to a drop in Trex's stock price [1] Financial Performance - Trex reported lower-than-anticipated sales for the third quarter of 2025 [1] - The company is taking measures to enable channel partners to carry lower inventory levels heading into year-end [1] Legal Context - Investors who purchased Trex stock and experienced losses are encouraged to contact Holzer & Holzer for legal assistance [2] - Holzer & Holzer is recognized as a top-rated securities litigation law firm, focusing on shareholder representation in litigation [3]

Core Insights - Holzer & Holzer, LLC is investigating HelloFresh SE for potential violations of federal securities laws following a report by Grizzly Research that claims the company's core demand is collapsing and that management is manipulating key performance indicators (KPIs) [1] - The report alleges that HelloFresh is emphasizing "high-value" customers while experiencing high churn rates, inflating growth figures due to rising food prices, and shifting focus to saturated, low-margin segments [1] - Following the publication of the report, HelloFresh's stock price experienced a decline [1] Company Overview - HelloFresh SE is a meal kit delivery service that has been facing scrutiny regarding its business practices and financial reporting [1] - The company is publicly traded under the ticker symbols OTC: HELFY and HLFFF [1] Legal Context - Holzer & Holzer, LLC is a law firm specializing in securities litigation and has a history of representing shareholders in cases of corporate misconduct [3] - The firm has been recognized as a top-rated securities litigation law firm for the years 2021, 2022, and 2023 [3] - Investors who have suffered losses from HelloFresh stock are encouraged to contact the firm for legal assistance [2]

Core Points - F5, Inc. is under investigation by Levi & Korsinsky for potential violations of federal securities laws following a significant security breach [1][2] - The breach involved unauthorized access by a sophisticated nation-state threat actor, which led to the exfiltration of sensitive files, including portions of the BIG-IP source code and information on undisclosed vulnerabilities [2] - The announcement of the breach resulted in a decline in F5's share price on the same day [2] Company Overview - F5, Inc. is a company that specializes in application services and delivery, with products like BIG-IP that are critical for managing application traffic and security [2] - The company has faced challenges related to cybersecurity, which could impact investor confidence and market performance [2] Legal Context - Levi & Korsinsky LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [3] - The firm is recognized as one of the top securities litigation firms in the United States, indicating its capability to handle complex cases effectively [3]

Core Points - Class Action Attorney Juan Monteverde's firm, Monteverde & Associates PC, has successfully recovered millions for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] - The firm is currently investigating Brighthouse Financial, Inc. regarding its proposed sale to Aquarian Holdings VI L.P., where Brighthouse shareholders are set to receive $70.00 in cash per share [1] Company Overview - Monteverde & Associates PC is a national class action securities firm located in the Empire State Building, New York City, with a successful track record in trial and appellate courts, including the U.S. Supreme Court [2] - The firm emphasizes its commitment to litigating on behalf of shareholders and has a history of recovering funds for them [2] Contact Information - For shareholders with concerns or seeking additional information, contact details for Juan Monteverde, Esq. are provided, including email and telephone [3]